Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells.

Oruetxebarria I, Venturini F, Kekarainen T, Houweling A, Zuijderduijn LM, Mohd-Sarip A, Vries RG, Hoeben RC, Verrijzer CP.

J Biol Chem. 2004 Jan 30;279(5):3807-16. Epub 2003 Nov 6.

2.

The mammalian SWI/SNF complex and the control of cell growth.

Muchardt C, Yaniv M.

Semin Cell Dev Biol. 1999 Apr;10(2):189-95. Review.

PMID:
10441072
3.

[Cyclin dependent kinase inhibitors and replicative senescence].

Gerland LM, Ffrench M, Magaud JP.

Pathol Biol (Paris). 2001 Dec;49(10):830-9. Review. French.

PMID:
11776695
4.

p16 and ARF: activation of teenage proteins in old age.

Satyanarayana A, Rudolph KL.

J Clin Invest. 2004 Nov;114(9):1237-40. Review.

5.

The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth.

Ivanchuk SM, Mondal S, Dirks PB, Rutka JT.

J Neurooncol. 2001 Feb;51(3):219-29. Review.

PMID:
11407594
6.

[Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].

Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J.

Cancer Radiother. 2001 Apr;5(2):109-29. Review. French.

PMID:
11355576
7.

Replicative senescence as a barrier to human cancer.

Parkinson EK, Munro J, Steeghs K, Morrison V, Ireland H, Forsyth N, Fitzsimmons S, Bryce S.

Biochem Soc Trans. 2000 Feb;28(2):226-33. Review.

PMID:
10816133
8.

Integrase interactor 1 in health and disease.

Das S.

Curr Protein Pept Sci. 2015;16(6):478-90. Review.

PMID:
25772157
9.

TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.

Lim IK.

J Cancer Res Clin Oncol. 2006 Jul;132(7):417-26. Epub 2006 Feb 3. Review.

PMID:
16456675
10.

Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health.

Popov N, Gil J.

Epigenetics. 2010 Nov-Dec;5(8):685-90. Epub 2010 Nov 1. Review.

11.

The ARF-p53 senescence pathway in mouse and human cells.

Wadhwa R, Sugihara T, Taira K, Kaul SC.

Histol Histopathol. 2004 Jan;19(1):311-6. doi: 10.14670/HH-19.311. Review.

PMID:
14702199
12.

The role of INI1/hSNF5 in gene regulation and cancer.

Stojanova A, Penn LZ.

Biochem Cell Biol. 2009 Feb;87(1):163-77. doi: 10.1139/O08-113. Review.

PMID:
19234532
13.

Dynamics of ARF regulation that control senescence and cancer.

Ko A, Han SY, Song J.

BMB Rep. 2016 Nov;49(11):598-606. Review.

14.

The molecular balancing act of p16(INK4a) in cancer and aging.

LaPak KM, Burd CE.

Mol Cancer Res. 2014 Feb;12(2):167-83. doi: 10.1158/1541-7786.MCR-13-0350. Epub 2013 Oct 17. Review.

15.

Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer.

Li J, Poi MJ, Tsai MD.

Biochemistry. 2011 Jun 28;50(25):5566-82. doi: 10.1021/bi200642e. Epub 2011 Jun 6. Review.

16.

Role of the p16 tumor suppressor gene in cancer.

Liggett WH Jr, Sidransky D.

J Clin Oncol. 1998 Mar;16(3):1197-206. Review.

PMID:
9508208
17.

Role of Ink4a/Arf locus in beta cell mass expansion under physiological and pathological conditions.

Salas E, Rabhi N, Froguel P, Annicotte JS.

J Diabetes Res. 2014;2014:873679. doi: 10.1155/2014/873679. Epub 2014 Feb 6. Review.

18.

[Cancer cells escape from failsafe programs in a simple Twist].

Puisieux A, Valsesia-Wittmann S.

Bull Cancer. 2006 Mar 1;93(3):251-6. Review. French.

19.

The Role of p16INK4a Pathway in Human Epidermal Stem Cell Self-Renewal, Aging and Cancer.

D'Arcangelo D, Tinaburri L, Dellambra E.

Int J Mol Sci. 2017 Jul 22;18(7). pii: E1591. doi: 10.3390/ijms18071591. Review.

20.

Macrophages, inflammation, and tumor suppressors: ARF, a new player in the game.

Trav├ęs PG, Luque A, Hortelano S.

Mediators Inflamm. 2012;2012:568783. doi: 10.1155/2012/568783. Epub 2012 Dec 18. Review.

Supplemental Content

Support Center